AAAAAA

   
Results: 1-25 | 26-50 | 51-69
Results: 26-50/69

Authors: Carozzi, T Karlsson, R Bergman, J
Citation: T. Carozzi et al., Parameters characterizing electromagnetic wave polarization, PHYS REV E, 61(2), 2000, pp. 2024-2028

Authors: Nurmi, E Ruottinen, HM Kaasinen, V Bergman, J Haaparanta, M Solin, O Rinne, JO
Citation: E. Nurmi et al., Progression in Parkinson's disease: A positron emission tomography study with a dopamine transporter ligand [F-18] CFT, ANN NEUROL, 47(6), 2000, pp. 804-808

Authors: Laihinen, A Ruottinen, H Rinne, JO Haaparanta, M Bergman, J Solin, O Koskenvuo, M Marttila, R Rinne, UK
Citation: A. Laihinen et al., Risk for Parkinson's disease: twin studies for the detection of asymptomatic subjects using [F-18]6-fluorodopa PET, J NEUROL, 247, 2000, pp. 110-113

Authors: Nurmi, E Bergman, J Eskola, O Solin, O Hinkka, SM Sonninen, P Rinne, JO
Citation: E. Nurmi et al., Reproducibility and effect of levodopa on dopamine transporter function measurements: A [F-18]CFT PET study, J CEREBR B, 20(11), 2000, pp. 1604-1609

Authors: Langlet, A Latypov, NV Wellmar, U Goede, P Bergman, J
Citation: A. Langlet et al., Synthesis and reactions of 5,5-dinitrobarbituric acid, TETRAHEDR L, 41(12), 2000, pp. 2011-2013

Authors: Witt, A Bergman, J
Citation: A. Witt et J. Bergman, Synthesis and reactions of some 2-vinyl-3H-quinazolin-4-ones, TETRAHEDRON, 56(37), 2000, pp. 7245-7253

Authors: Bergman, J Janosik, T Yudina, L Desarbre, E Lidgren, G Venemalm, L
Citation: J. Bergman et al., Reactions of 1,2-bis(1H-indol-2-yl)ethane: Formation of indolo[2,3-c]carbazole and cyclohept[1,2-b : 5,4-b ']bisindole derivatives, TETRAHEDRON, 56(13), 2000, pp. 1911-1916

Authors: Ruottinen, HM Partinen, M Hublin, C Bergman, J Haaparanta, M Solin, O Rinne, JO
Citation: Hm. Ruottinen et al., An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome, NEUROLOGY, 54(2), 2000, pp. 502-504

Authors: Klutke, JJ Bergman, J Klutke, CG
Citation: Jj. Klutke et al., Transvaginal bladder neck suspension with Cooper's ligament fixation - Long-term urodynamic results, J REPRO MED, 45(7), 2000, pp. 541-545

Authors: Yang, Y Griffiths, WJ Nordling, M Nygren, J Moller, L Bergman, J Liepinsh, E Otting, G Gustafsson, JA Rafter, J Sjovall, J
Citation: Y. Yang et al., Ring opening of benzo[a]pyrene in the germ-free rat is a novel pathway forformation of potentially genotoxic metabolites, BIOCHEM, 39(50), 2000, pp. 15585-15591

Authors: Rinne, JO Portin, R Ruottinen, H Nurmi, E Bergman, J Haaparanta, M Solin, O
Citation: Jo. Rinne et al., Cognitive impairment and the brain dopaminergic system in Parkinson disease - [F-18]fluorodopa positron emission tomographic study, ARCH NEUROL, 57(4), 2000, pp. 470-475

Authors: Salokangas, RKR Vilkman, H Ilonen, T Taiminen, T Bergman, J Haaparanta, M Solin, O Alanen, A Syvalahti, E Hietala, J
Citation: Rkr. Salokangas et al., High levels of dopamine activity in the basal ganglia of cigarette smokers, AM J PSYCHI, 157(4), 2000, pp. 632-634

Authors: Laakso, A Vilkman, H Alakare, B Haaparanta, M Bergman, J Solin, O Peurasaari, J Rakkolainen, V Syvalahti, E Hietala, J
Citation: A. Laakso et al., Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography, AM J PSYCHI, 157(2), 2000, pp. 269-271

Authors: Laakso, A Vilkman, H Kajander, J Bergman, J Haaparanta, M Solin, O Hietala, J
Citation: A. Laakso et al., Prediction of detached personality in healthy subjects by low dopamine transporter binding, AM J PSYCHI, 157(2), 2000, pp. 290-292

Authors: Srinivasan, PT Viraraghavan, T Bergman, J
Citation: Pt. Srinivasan et al., Factors influencing residual aluminium levels at the Buffalo Pound Water Treatment Plant, Saskatchewan, Canada, J WAT SER T, 48(4), 1999, pp. 167-175

Authors: Kahkonen, M Harila-Saari, A Metsahonkala, L Korhonen, T Norvasuo-Heila, MK Utriainen, T Ahonen, A Bergman, J Salmi, TT Minn, H
Citation: M. Kahkonen et al., Cerebral blood flow and glucose metabolism in long-term survivors of childhood acute lymphoblastic leukaemia, EUR J CANC, 35(7), 1999, pp. 1102-1108

Authors: Hietala, J Syvalahti, E Vilkman, H Vuorio, K Rakkolainen, V Bergman, J Haaparanta, M Solin, O Kuoppamaki, M Eronen, E Ruotsalainen, U Salokangas, RKR
Citation: J. Hietala et al., Depressive symptoms and presynaptic dopamine function in neuroleptic-naiveschizophrenia, SCHIZOPHR R, 35(1), 1999, pp. 41-50

Authors: Bergman, J Brimert, T
Citation: J. Bergman et T. Brimert, Synthesis of 5-and 7-nitro-3-hydroxyquinolin-2-ones, ACT CHEM SC, 53(8), 1999, pp. 616-619

Authors: Bergman, J Brimert, T
Citation: J. Bergman et T. Brimert, Addition of secondary amines to maleamic esters and maleimides, ACT CHEM SC, 53(1), 1999, pp. 48-56

Authors: Rinne, JO Bergman, J Ruottinen, H Haaparanta, M Eronen, E Oikonen, V Sonninen, P Solin, O
Citation: Jo. Rinne et al., Striatal uptake of a novel PET ligand, [F-18]beta-CFT, is reduced in earlyParkinson's disease, SYNAPSE, 31(2), 1999, pp. 119-124

Authors: Harbecke, O Dahlgren, C Bergman, J Moller, L
Citation: O. Harbecke et al., The synthetic non-toxic drug 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-(2,3-b)quinoxaline inhibits neutrophil production of reactive oxygen species, J LEUK BIOL, 65(6), 1999, pp. 771-777

Authors: Klutke, JJ Klutke, CG Bergman, J Elia, G
Citation: Jj. Klutke et al., Bladder neck suspension for stress urinary incontinence: How does it work?, NEUROUROL U, 18(6), 1999, pp. 623-627

Authors: Tholander, J Bergman, J
Citation: J. Tholander et J. Bergman, Probing the TCDD receptor: Synthesis of 5,6-dihydro-6a,11,11b-triazabenzo[a]fluorene center dot PF6, a potential ligand, HETEROCYCLE, 51(6), 1999, pp. 1275

Authors: West, M Rose, SM Spreng, S Verhoef, M Bergman, J
Citation: M. West et al., Anxious attachment and severity of depressive symptomatology in women, WOMEN HEAL, 29(1), 1999, pp. 47-56

Authors: Takala, TO Nuutila, P Katoh, C Luotolahti, M Bergman, J Maki, M Oikonen, V Ruotsalainen, U Gronroos, T Haaparanta, M Kapanen, S Knuuti, J
Citation: To. Takala et al., Myocardial blood flow, oxygen consumption, and fatty acid uptake in endurance athletes during insulin stimulation, AM J P-ENDO, 277(4), 1999, pp. E585-E590
Risultati: 1-25 | 26-50 | 51-69